Skip to main content
. Author manuscript; available in PMC: 2015 Feb 27.
Published in final edited form as: Circulation. 2013 Nov 18;129(2):145–156. doi: 10.1161/CIRCULATIONAHA.113.006641

Figure 5.

Figure 5

SR Ca2+-ATPase (Serca2a) and phospholamban (PLB) expression, phosphorylation and function in Ctl and pAF-patients. A. Representative Western blots (top) for total Serca2a and total PLB protein-expression, as well as Ser16-PLB phosphorylation, Thr17-PLB phosphorylation, and calsequestrin (CSQ) expression. Bottom panel shows quantification of total Serca2a and PLB expression, and relative Ser16/Thr17 PLB phosphorylation-levels. Group data are normalized to CSQ. B. Representative example of a caffeine experiment, highlighting the decay rate of the systolic (ICa,L-triggered) Ca2+-transient (ksyst) and the decay rate of the caffeine-induced Ca2+-transient (kcaff). C. Respective rate-constants ksyst (left), kcaff (middle) and kSerca (right, obtained as the difference between ksyst and kcaff) in Ctl and pAF-patients. Numbers indicate tissue samples per group (panel A) or myocytes/patients (panel C). *P<0.05 vs. Ctl. Comparisons using one-way ANOVA (A) or multi-level mixed-effects models (C).